BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34304918)

  • 1. Re: Comparison of the eighth edition of the TNM and Brigham Women's Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review.
    Chang C; Munro SP; Kyle D
    Br J Oral Maxillofac Surg; 2021 Dec; 59(10):1320-1321. PubMed ID: 34304918
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the eighth edition of the TNM and Brigham Women's Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review.
    Bowe CM; Walsh S
    Br J Oral Maxillofac Surg; 2021 Dec; 59(10):1322-1323. PubMed ID: 34266702
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the eighth edition of the TNM and Brigham Women's Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review.
    Bowe CM; Houlton S; Walsh S
    Br J Oral Maxillofac Surg; 2020 Nov; 58(9):1158-1163. PubMed ID: 33071049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma.
    Puebla-Tornero L; Corchete-Sánchez LA; Conde-Ferreirós A; García-Sancha N; Corchado-Cobos R; Román-Curto C; Cañueto J
    J Am Acad Dermatol; 2021 Apr; 84(4):938-945. PubMed ID: 33333151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Staging Systems for Non-Head and Neck Cutaneous Squamous Cell Carcinoma.
    Guerra R; Shahwan KT; Nikahd M; Hyer M; Carr DR
    Dermatol Surg; 2024 Feb; 50(2):121-124. PubMed ID: 37962141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
    Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
    J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinician perspectives on the factors influencing prognostic stratification by the American Joint Commission on Cancer Head and Neck Cutaneous Squamous Cell Carcinoma Staging.
    Watts F; Palme CE; Porceddu S; Sundaresan P; Clark JR; Gupta R
    Surgery; 2021 Nov; 170(5):1467-1473. PubMed ID: 34130810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pros and Cons of the New Edition of TNM Classification of Head and Neck Squamous Cell Carcinoma.
    Denaro N; Russi EG; Merlano MC
    Oncology; 2018; 95(4):202-210. PubMed ID: 29975952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Sood A; Wykes J; Roshan D; Wang LY; McGuinness J; Fowler A; Ebrahimi A
    Head Neck; 2019 Jun; 41(6):1591-1596. PubMed ID: 30659690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
    Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
    Ruiz ES; Karia PS; Besaw R; Schmults CD
    JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical analysis of the 8th edition TNM staging for head and neck cutaneous squamous cell carcinoma with lymph node metastases and comparison to N1S3 stage and ITEM risk score: A multicenter study.
    Ebrahimi A; Luk PP; Low H; McDowell L; Magarey MJR; Smith PN; Perriman DM; Veness M; Gupta R; Clark JR
    J Surg Oncol; 2021 Jun; 123(7):1531-1539. PubMed ID: 33721339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma.
    Upton M; Kita A; Scapa J; St John M
    Laryngoscope; 2021 Jan; 131(1):E170-E175. PubMed ID: 32212346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the AJCC N staging system in mucosal and cutaneous squamous head and neck cancer.
    Brunner M; Ng BC; Veness MJ; Clark JR
    Laryngoscope; 2014 Jul; 124(7):1598-602. PubMed ID: 24307576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Poor Outcome for Cutaneous Squamous Cell Carcinoma of the Head and Neck Comparing Classification Systems: A Competing Risk Analysis.
    Leus AJG; van Dijk BAC; Postmus D; Plaat BEC; Halmos GB; Diercks GFH; Rácz E; van Kester MS
    J Invest Dermatol; 2022 Sep; 142(9):2532-2534.e4. PubMed ID: 35304251
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck.
    Amit M; Liu C; Netto Gleber FO; Kini S; Tam S; Benov A; Aashiq M; El-Naggar AK; Moreno AC; Rosenthal DI; Glisson BS; Ferrarotto R; Wong MK; Migden MR; Li G; Khanna A; Goepfert RP; Nagarajan P; Weber RS; Myers JN; Gross ND
    Eur J Cancer; 2021 Feb; 144():169-177. PubMed ID: 33352413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
    Inda JJ; Kabat BF; Larson MC; Slager SL; Baum CL
    J Am Acad Dermatol; 2019 Mar; 80(3):639-645. PubMed ID: 30165169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number of nodal metastases and prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Sood A; Wykes J; Roshan D; Wang LY; McGuinness J; Forstner D; Fowler A; Lee M; Kernohan M; Ngo Q; Estall V; Ebrahimi A
    ANZ J Surg; 2019 Jul; 89(7-8):863-867. PubMed ID: 30974495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
    Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
    Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.